Article: Granulocytic sarcoma with expression of CD30

A case of a young man with a spinal epidural tumour, initially diagnosed as large cell anaplastic malignant lymphoma, is reported. The tumour consisted of poorly differentiated cells showing immunoreactivity with antibodies directed against CD30 and CD45. Ten months later the patient developed acute myeloid leukaemia. The histological slides of the epidural tumour were reviewed, including additional enzymochemical and immunochemical stains. As the tumour showed immunoreactivity for myeloperoxidase and chloroacetate esterase, it was reclassified as a granulocytic sarcoma.

Citing Articles

Epidural myeloid sarcoma as the presenting symptom of chronic myeloid leukemia blast crisis.

Slouma M, Rahmouni S, Dhahri R, Khayati Y, Zriba S, Amorri W Clin Rheumatol. 2020; 39(8):2453-2459.

PMID: 32458246 DOI: 10.1007/s10067-020-05167-4.

A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors.

Sharman J, Wheler J, Einhorn L, Dowlati A, Shapiro G, Hilton J Invest New Drugs. 2019; 37(4):738-747.

PMID: 30993587 PMC: 6647393. DOI: 10.1007/s10637-019-00768-6.

Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility.

Li B, Eschrich S, Berglund A, Mitchell M, Fenstermacher D, Danaee H JMIR Res Protoc. 2017; 6(3):e45.

PMID: 28320689 PMC: 5379017. DOI: 10.2196/resprot.7289.

Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece.

Campo E, Chott A, Kinney M, Leoncini L, Meijer C, Papadimitriou C Histopathology. 2006; 48(5):481-504.

PMID: 16623775 PMC: 1448691. DOI: 10.1111/j.1365-2559.2006.02369.x.

Multi-lineage interrogation of the performance characteristics of a split-signal fluorescence in situ hybridization probe for anaplastic lymphoma kinase gene rearrangements: a study of 101 cases characterized by immunohistomorphology on fixed....

Tan L, Do E, Tan S, Chong S, Koay E Mol Diagn. 2005; 8(4):213-29.

PMID: 15887977 DOI: 10.1007/BF03260066.

References

1.

NEIMAN R, Barcos M, Berard C, Bonner H, Mann R, RYDELL R . Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer. 1981; 48(6):1426-37. DOI: 10.1002/1097-0142(19810915)48:6<1426::aid-cncr2820480626>3.0.co;2-g. View

2.

STEIN H, Gerdes J, Schwab U, Lemke H, Mason D, Ziegler A . Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population. Int J Cancer. 1982; 30(4):445-59. DOI: 10.1002/ijc.2910300411. View

3.

Andreesen R, Osterholz J, LOHR G, Bross K . A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts. Blood. 1984; 63(6):1299-302. View

4.

Meis J, Butler J, Osborne B, Manning J . Granulocytic sarcoma in nonleukemic patients. Cancer. 1986; 58(12):2697-709. DOI: 10.1002/1097-0142(19861215)58:12<2697::aid-cncr2820581225>3.0.co;2-r. View

5.

Traweek S, Arber D, Rappaport H, Brynes R . Extramedullary myeloid cell tumors. An immunohistochemical and morphologic study of 28 cases. Am J Surg Pathol. 1993; 17(10):1011-9. DOI: 10.1097/00000478-199310000-00006. View

Granulocytic Sarcoma with Expression of CD30